At the recent annual meeting of the Swiss Society of Neurosurgery in Interlaken, Prof. Dr. med. Jehuda Soleman, representing the EMINENT-ICH Core Team, presented the results of the ENRICH trial and led a discussion on the controversies in the management of spontaneous supratentorial intracerebral haemorrhage (SSICH) following the trial's findings.
You can find his entire presenation here.
Comments